The State Council voices that the hospital shall not default on the payment of money to the dealer.

Medical Network August 10th, medical permens dream every night is back to... 1, the State Council: to ensure 30 days of repayment on August 6, the State Council official website issued "small and medium-sized enterprises this money, the State Council said can not owe!" A article shows that the current stability of the basic economic plate to focus on helping small and medium-sized enterprises to tide over the difficulties, to protect the payment of small and medium-sized enterprises this matter has been urgent.
it is understood that the State Council recently issued the Regulations on the Protection of Payments to Small and Medium-sized Enterprises (hereinafter referred to as the Regulations), which will come into effect on September 1, 2020 (the interpretation of the text and the interpretation of the text, as well as the self-test of the size of enterprises).
the Regulations of the Regulations, the terms of payment are clearly stipulated, and the purchase of goods, works and services by organs and institutions from small and medium-sized enterprises shall be made within 30 days from the date of delivery of goods, works and services, and if the contract is otherwise agreed, the payment term shall not exceed 60 days.
at present, China's public hospitals or cancellation of the establishment of public institutions, but still belong to the nature of public institutions.
Regulations also require organs, institutions and large enterprises not to require sMEs to accept unreasonable payment terms, modalities, conditions and liability for breach of contract and other transaction conditions, and not to default on the arrears of goods, works and services to sMEs.
in China's armed enterprises, most of them are small and medium-sized enterprises. On August 5,
, the State Drug Administration released the 2019 Annual Report on Drug Regulatory Statistics, showing that by the end of 2019, there were 18,000 medical device manufacturers nationwide, an increase of 1,000 from 2018.
8232 enterprises that can produce one kind of products, 10033 enterprises that can produce two types of products, and 1977 enterprises that can produce three types of products.
as of the end of 2019, there are 593,000 medical device business enterprises in the second and third categories, an increase of 82,000 plus compared to 2018, of which only 347,000 are engaged in two types of medical device products, 69,000 are engaged in three types of medical device products, and 177,000 are enterprises operating two or three types of medical device products.
According to the Medical Device Blue Book: China's Medical Device Industry Development Report (2019), more than 90% of China's medical device manufacturers are small and medium-sized enterprises, with an average annual income of 30 million to 40 million yuan.
2, the country's arrears of more than 890 billion yuan on January 17 this year, according to the People's Daily news, Vice Minister of Industry and Information Technology Xin Guobin in the State Council Information Office held a regular briefing on state policy briefing, said that as of the end of December 2019, government departments at all levels and large state-owned enterprises combed out arrears of private enterprises small micro-enterprise accounts of more than 890 billion yuan, at that time has paid off more than 660 billion yuan, the progress of about 75 percent.
Xin Guobin said that although the remaining more than 200 billion yuan in arrears accounts accounts only accounted for 25%, but the task of settlement is more difficult.
analysis of the remaining arrears for the year shows that non-divisive arrears account for more than 80 per cent.
most of these arrears are old accounts, the cause is particularly complex, coupled with some local financial resources are relatively tight, some arrears of enterprise production and operation difficulties, so the late liquidation task should be hard to chew.
, the Regulations emphasize the prohibition of disguised arrears of payment, and stipulate that if organs, institutions and large enterprises use non-cash payment methods such as commercial bills of exchange to pay for small and medium-sized enterprises, they shall make a clear and reasonable agreement in the contract, and shall not force small and medium-sized enterprises to accept non-cash payment methods such as commercial bills of exchange, and shall not use non-cash payment methods such as commercial bills of exchange to extend the payment period in disguise.
in fact, in addition to this State Council issue, in December 2019, the Ministry of Industry and Information Technology issued the "Public consultation on the timely payment of small and medium-sized enterprises in the management measures (draft for comments) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
also explicitly requires that state organs, institutions and large enterprises should not abuse their dominant position in the transaction and force sized enterprises to accept unreasonable payment terms, modalities, conditions and liability for breach of contract.
if a large enterprise abuses its market advantage position to force a small and medium-sized enterprise to accept unreasonable payment terms or delay in making payments to a small and medium-sized enterprise, it shall be ordered by the market supervision and administration department to make corrections and impose a fine of 100,000 yuan to 500,000 yuan or less. Similar
to the Regulations, the Draft for Comments also shows that state organs, institutions and large enterprises that purchase goods, works and services from small and medium-sized enterprises shall pay within 30 days; if the
contract stipulates that inspection or acceptance shall be used as a condition of payment, the above term may be extended by up to 30 days.
for the responsibility for late payment, the Opinions clearly state organs, institutions and large enterprises shall pay overdue interest if they delay the payment of payments to small and medium-sized enterprises.
3, the pressure of arms enterprises capital or become larger in the current market situation, the withdrawal of arms enterprises and capital pressure seems to have increased. On July 25,
, Dabo Medical announced that its repayment cycle was getting longer.
it is understood that at the end of 2019, Dabo Medical Accounts Receivable sbalance of 261 million yuan, bad debt provision of 0.23 billion yuan, accounts receivable this reporting period turnover days increased from 85.41 days in 2018 to 249.71 days, the current period recovery or return of bad debt provision amount of 23.386 million yuan.
in recent years, with the orthopaedic implantsupplies two-vote system in some provinces gradually implemented, its sales model gradually from the distribution model to the distribution model to change.
and distribution mode is relatively comparable, distribution mode, distributor sales to hospitalbey because of better hospital credit, so accounts receivable quality is better, the risk of bad debts is lower, but the return cycle is also longer.
in addition, june 1, according to the Shanghai Stock Exchange official website information, Ningbo Tianyi Medical Devices Co., Ltd. in the latest issue of the prospectus, said that after the implementation of the two-vote system, the company's repayment is not affected, but the one-vote system will lead to a change in the company's repayment cycle.
said that if the future "one-vote system" in the field of medical device circulation, a wide range of strict implementation, the issuer will be directly settled with the medical insurance fund, the issuer's sales and settlement model will be to first-served goods-based into a first-served after-the-line, the return cycle or will become longer.
Nanchang University also published a paper analysis that under the influence of the two-vote system, the competition between the pharmaceutical circulation industry is becoming more intense, the overall growth rate of the industry will be slowed down, the probability of financial risks in the pharmaceutical circulation industry will continue to increase. in addition, the
, the pharmaceutical and equipment industry due to large capital investment, long repayment cycle, so that most of the enterprise debt management.
statistics, the industry's average asset-liability ratio is more than 70%, from 2013 to 2017, the average asset-liability ratio from 76.8% to 72.95 percent, but the return on assets has remained basically unchanged, stable at about 18.5 percent.
the high asset-liability ratio of the circulation industry indicates that the industry has a high financial risk, stakeholders and relevant managers should pay sufficient attention.
attachments: